Singapore markets close in 7 hours 32 minutes
Straits Times Index
3,307.52 +10.63 (+0.32%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,207.13 +444.10 (+2.50%) FTSE 100
8,172.15 +50.91 (+0.63%) Bitcoin USD
59,457.04 +1,779.53 (+3.09%) CMC Crypto 200
1,279.18 +8.44 (+0.66%)
GSK Jan 2025 32.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:36AM EDT. Market open.
| Previous close | 8.39 |
| Open | 8.39 |
| Bid | 10.40 |
| Ask | 13.40 |
| Strike | 32.00 |
| Expiry date | 2025-01-17 |
| Day's range | 8.39 - 8.39 |
| Contract range | N/A |
| Volume | |
| Open interest | 268 |
Simply Wall St.GSK First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
GSK ( LON:GSK ) First Quarter 2024 Results Key Financial Results Revenue: UK£7.36b (up 5.9% from 1Q 2023). Net income...
BenzingaGSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Wednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling Pounds), up 10% Y/Y and 13% excluding COVID. Vaccines’ sales increased 16% at constant currency to 2.28 billion Pounds, reflecting U.S. demand for Arexvy and strong market growth for Shingrix in International and European markets. Shingrix sales reached 945 million Pounds, up 18% at constant currency, with Arexvy sales of 182 million Pounds. Specialty Medicine sales increased 17% to 2.5 billion poun
PA Media: MoneyGSK raises profit guidance as vaccine demand grows
Emma Walmsley, chief executive officer of the pharmaceutical firm hailed a ‘strong start to 2024’.
© 2024 Yahoo. All rights reserved.